Anbio Biotechnology Class A NNNN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $10.61
- Day Range
- $9.90–11.41
- 52-Week Range
- $8.30–54.95
- Bid/Ask
- $9.80 / $11.65
- Shares Outstanding
- 43.89M
- Market Cap
- $447.25M
- Volume/Avg
- 59,071 / 40,127
Key Statistics
- Price/Earnings (Normalized)
- 72.18
- Price/Sales
- 53.59
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 27
- Website
- https://www.anbio.com
Valuation
|
Metric
|
NNNN
|
|---|---|
Price/Earnings (Normalized) | 72.18 |
Price/Book Value | 15.44 |
Price/Sales | 53.59 |
Price/Cash Flow | 71.60 |
Price/Earnings
NNNN
Financial Strength
|
Metric
|
NNNN
|
|---|---|
Quick Ratio | 177.13 |
Current Ratio | 344.31 |
Interest Coverage | — |
Quick Ratio
NNNN
Profitability
|
Metric
|
NNNN
|
|---|---|
Return on Assets (Normalized) | 25.26% |
Return on Equity (Normalized) | 25.92% |
Return on Invested Capital (Normalized) | 25.35% |
Return on Assets
NNNN
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|f&H@xR@ | LOCK|$Q^ | $134B | |||
| Becton Dickinson & Co
BDX
| LOCK|r<> | LOCK|!wMM? | $48B | |||
| Alcon Inc
ALC
| LOCK|&JQ^!B | LOCK|@><d | $34B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|cZ&jc> | LOCK|@<W> | $31B | |||
| ResMed Inc
RMD
| LOCK|!kx>rlV | LOCK|$x?<@ | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|mnl>%<J | LOCK|^?b | $25B | |||
| The Cooper Companies Inc
COO
| LOCK|KRP#%z | LOCK|g>@# | $14B | |||
| Baxter International Inc
BAX
| LOCK|G@ | LOCK|?&ZR | $14B | |||
| Solventum Corp
SOLV
| LOCK|X&RHbC | LOCK|<L# | $14B | |||
| Align Technology Inc
ALGN
| LOCK|l?TF^v | LOCK|s!y^! | $12B |
United States